中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
N-乙酰基-1-O-(苯基甲基)-4,6-O-(苯基亚甲基)-ALPHA-胞壁酸 | Benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-3-O-<(R)-1-carboxyethyl>-α-D-glucopyranoside | 2862-03-5 | C25H29NO8 | 471.507 |
—— | N-acetylmuramic acid | 73089-68-6 | C25H29NO8 | 471.507 |
苄基-2-乙酰胺基-2-脱氧-Alpha-D-吡喃葡萄糖苷 | benzyl 2-acetamido-2-deoxy-α-D-glucopyranoside | 13343-62-9 | C15H21NO6 | 311.335 |
—— | benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-α-D-glucopyranoside | 78246-81-8 | C22H25NO6 | 399.444 |
—— | D-GlcNAc | 7512-17-6 | C8H15NO6 | 221.21 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | 2-(benzenesulfonyl)ethyl (2R)-2-[(2S,3R,4R,5S,6R)-5-[[(2R,4aR,6S,7R,8aS)-2-phenyl-7-(2,2,2-trichloroethoxycarbonylamino)-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-3-acetamido-2-phenylmethoxy-6-(phenylmethoxymethyl)oxan-4-yl]oxypropanoate | 919078-15-2 | C49H55Cl3N2O15S | 1050.41 |
—— | P1-uridin-5'-yl P2-[(2-acetamido-2-deoxy-β-D-glucopyranosyl)-(1->4)-2-acetamido-2-deoxy-3-O-(D-1-carboxyethyl)-α-D-glucopyranosyl] diphosphate | —— | C28H44N4O24P2 | 882.617 |
—— | P1-uridin-5'-yl P2-[(2-acetamido-2-deoxy-β-D-glucopyranosyl)-(1->4)-2-acetamido-2-deoxy-3-O-(D-2-propionyl-L-alanyl-D-glutamic diamide)-α-D-glucopyranosyl] diphosphate | —— | C36H58N8O26P2 | 1080.84 |
—— | P1-uridin-5'-yl P2-[(2-acetamido-2-deoxy-β-D-glucopyranosyl)-(1->4)-2-acetamido-2-deoxy-3-O-(D-2-propionyl-L-alanyl-L-lysinamide)-α-D-glucopyranosyl] diphosphate | —— | C37H62N8O25P2 | 1080.89 |
—— | P1-uridin-5'-yl P2-[(2-acetamido-2-deoxy-β-D-glucopyranosyl)-(1->4)-2-acetamido-2-deoxy-3-O-(D-2-propionyl-L-alanyl-Nε-dansyl-L-lysinamide)-α-D-glucopyranosyl] diphosphate | —— | C49H73N9O27P2S | 1314.18 |
A series of UDP-disaccharide peptide compounds were synthesized as synthetic substrate analogues or potential inhibitors of glycosyl transferase. Fluorescent compounds have been prepared with the aim of developing a screening method for selecting transglycosylase inhibitors.